COMMUNIQUÉS West-GlobeNewswire

-
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/03/2025 - 13:00 -
Sienna Announces March Dividend
14/03/2025 - 13:30 -
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108
14/03/2025 - 13:30 -
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
14/03/2025 - 13:30 -
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
14/03/2025 - 13:30 -
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
14/03/2025 - 13:30 -
Hepion Pharmaceuticals Announces Reverse Stock Split
14/03/2025 - 13:30 -
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
14/03/2025 - 13:35 -
Healthcare Integrated Technologies Inc. Successfully Raises $10 million in Friends & Family Funding
14/03/2025 - 14:15 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
14/03/2025 - 14:30 -
Notice to Convene Annual General Meeting 2025 - Item 6: Election of members to the Board of Directors
14/03/2025 - 15:30 -
Blue Antioxidant: How Prime Biome Restores Skin with 10x Retinol Strength
14/03/2025 - 15:37 -
Fifty 1 Labs, Inc. Completes Name and Symbol Change, Advances Toward Regaining 15c211 Compliance
14/03/2025 - 16:00 -
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14/03/2025 - 21:00 -
ExoPTEN Preclinical Study Demonstrates Significant Potential for Enhancing Motor Function, Blood Flow, and Spinal Cord Injury Recovery
14/03/2025 - 21:03 -
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters' Over-Allotment Option in Initial Public Offering
14/03/2025 - 21:05 -
Pacira BioSciences Confirms Receipt of Director Nominations from DOMA Perpetual
14/03/2025 - 21:05 -
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement
14/03/2025 - 21:30 -
Arch Biopartners Closes Non-Brokered Private Placement
14/03/2025 - 21:30
Pages